Clinical trials
Suspended Phase 1 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 4 |
| National Cancer Institute (NCI) | 2 |
| David Wald | 1 |
| Fred Hutchinson Cancer Center | 1 |
| He Huang | 1 |
| Huda Salman | 1 |
| University of Chicago | 1 |
| University of Maryland, Baltimore | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 13 |
| Myelodysplastic Syndromes | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Hematologic Neoplasms | 2 |
| Colorectal Neoplasms | 1 |
| Enteropathy-Associated T-Cell Lymphoma | 1 |
| Esophageal Neoplasms | 1 |
| GATA2 Deficiency | 1 |
| Hodgkin Disease | 1 |
| Immunoblastic Lymphadenopathy | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.